Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - 9 months ended Sep. 30, 2016 - USD ($)
Total
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid In Capital [Member]
Stockholder Note Receivable [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Series A Convertible Preferred Stock [Member]
Balance at Dec. 31, 2015 $ 6,086,766 $ 76,573 $ 0 $ 71,209,530 $ (58,824) $ 114,788 $ (65,255,301) $ 0
Balance (in shares) at Dec. 31, 2015   7,657,287 0         0
Stock-Based Compensation 390,469     390,469        
Shares Issued to Jade Therapeutics, Inc. Stockholders at Acquisition 2,909,766 $ 6,891 $ 291,536 2,611,339        
Shares Issued to Jade Therapeutics, Inc. Stockholders at Acquisition (in shares)   689,157 76,571          
Issuance of Holdback Shares from the Jade Acquisition 0 $ 227 $ (86,329) 86,102        
Issuance of Holdback Shares from the Jade Acquisition (in shares)   22,674 (22,674)          
Forfeiture of Holdback Shares from the Jade Acquisition 0   $ (205,207) 205,207        
Forfeiture of Holdback Shares from the Jade Acquisition (in shares)     (53,897)          
Issuance of Common Stock in Offering, Net of Offering Costs 668,437 $ 4,410   664,027        
Issuance of Common Stock in Offering, Net of Offering Costs (in shares)   441,000            
Issuance of Series A Preferred Stock, Net of Offering Costs 2,776,447     2,776,419       $ 28
Issuance of Series A Preferred Stock, Net of Offering Costs (in shares)               2,777
Conversion of Series A Preferred Stock 0 $ 6,890   (6,874)       $ (16)
Conversion of Series A Preferred Stock (in shares)   689,000           (1,551)
Exercise of Common Stock Options 56,206 $ 868   55,338        
Exercise of Common Stock Options (in shares)   86,765            
Foreign Currency Translation Adjustment (344)         (344)    
Net Loss Attributable to Common Stockholders (9,642,376)           (9,642,376)  
Balance at Sep. 30, 2016 $ 3,245,371 $ 95,859 $ 0 $ 77,991,557 $ (58,824) $ 114,444 $ (74,897,677) $ 12
Balance (in shares) at Sep. 30, 2016   9,585,883 0         1,226